EUVIMEDEUVIMED entdecken
Crossref

Development of Thermosensitive Mucoadhesive Gel Based Encapsulated Lipid Microspheres as Nose-to-Brain Rivastigmine Delivery System

Nurafni Annisa Achmad, Rachmatya W Tuna, Irfan Kurniawan, Khairiyah, Muhammad Bisfain Asaf, Latifah Rahman, Marianti A Manggau iD, Aliyah, Juan Dominguez-Robles, Muhammad Aswad, Andi Dian Permana iD

Langmuir · 2025

DOI: 10.1021/acs.langmuir.4c03530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Langmuir, 2025. Verfasst von Nurafni Annisa Achmad und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Hasanuddin University, Makassar 90245, South Sulawesi, Indonesia. Hauptthemen laut MEDLINE: Rivastigmine, Microspheres, Brain, Lipids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Badan Riset dan Inovasi Nasional.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (ALZ) is a neurodegenerative disease that damages neuronal cells and causes decline in cognitive abilities. Administration of cholinesterase inhibitor compounds is the primary choice in the treatment of ALZ, one of which is rivastigmine (RVT). Several routes of administration of RVT are available, such as oral and transdermal. However, in the oral route, RVT has low bioavailability, undergoes first-pass metabolism, and the presence of the blood-brain barrier (BBB) reduces the therapeutic concentration of RVT. The transdermal route is nonselective target in the brain. This study aims to combine thermosensitive mucoadhesive gel (TG) and lipid microspheres (LM) as a drug delivery system to improve the efficacy of RVT. Combining these will prevent systemic side effects of RVT and increase drug concentration in the brain. LM was formulated with varying concentrations of Compritol polymer. The results of LM evaluation showed the values of particle size, PDI, and %EE and %DL were 8.519 μm, 0.018 ± 0.004, 72.54%, and 76.43%, respectively. The TG formulation can provide a liquid form at room temperature (25 °C) and a gel at nasal temperature (35 °C). Hemolytic and HET-CAM tests confirmed TG RVT LM's safety for use. Ex vivo studies showed controlled and sustained release of TG RVT LM, and in vivo studies showed TG RVT LM a higher pharmacokinetic profile in the brain than oral formulations and injections. The Cmax was found to be 7.05 ± 0.55 μg/cm3, Tmax was 24 h, and AUC0-24, which is related to the effectiveness of brain targeting, was 225.73 μg/cm3. In conclusion, this study shows the successful development of TG RVT LM, as evidenced by improved drug delivery to the brain, which is characterized by higher concentrations of RVT in the brain compared with oral and injectable RVT, this delivery system shows potential as a future treatment for Alzheimer's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RivastigmineMicrospheresBrainLipidsTemperatureDrug Delivery SystemsGelsAnimalsParticle SizeAdministration, IntranasalNasal MucosaDrug LiberationRats

Substanzen

RivastigmineGelsLipids

Autor:innen und Institutionen

  • Faculty of Pharmacy, Hasanuddin University, Makassar 90245, South Sulawesi, Indonesia.
  • Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Seville 41012, Spain.

ORCID-Profile: Marianti A Manggau, Andi Dian Permana

Förderung

  • Badan Riset dan Inovasi Nasional

Zitieren

APA

Achmad, N. A., Tuna, R. W., Kurniawan, I., Khairiyah, Asaf, M. B., Rahman, L., Manggau, M. A., Aliyah, Dominguez-Robles, J., Aswad, M., & Permana, A. D. (2025). Development of Thermosensitive Mucoadhesive Gel Based Encapsulated Lipid Microspheres as Nose-to-Brain Rivastigmine Delivery System. Langmuir. https://doi.org/10.1021/acs.langmuir.4c03530

Vancouver

Achmad NA, Tuna RW, Kurniawan I, Khairiyah, Asaf MB, Rahman L, et al. Development of Thermosensitive Mucoadhesive Gel Based Encapsulated Lipid Microspheres as Nose-to-Brain Rivastigmine Delivery System. Langmuir. 2025. doi:10.1021/acs.langmuir.4c03530

BibTeX
@article{Achmad2025,
  author = {Achmad, Nurafni Annisa and Tuna, Rachmatya W and Kurniawan, Irfan and Khairiyah and Asaf, Muhammad Bisfain and Rahman, Latifah and Manggau, Marianti A and Aliyah and Dominguez-Robles, Juan and Aswad, Muhammad and Permana, Andi Dian},
  title = {Development of Thermosensitive Mucoadhesive Gel Based Encapsulated Lipid Microspheres as Nose-to-Brain Rivastigmine Delivery System},
  journal = {Langmuir},
  year = {2025},
  doi = {10.1021/acs.langmuir.4c03530}
}
Kostenlos starten →